Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Issues in hyperlipidemic pancreatitis.

Dhiraj Yadav1, C S Pitchumoni

  • 1Our Lady of Mercy University Medical Center, New York Medical College, Bronx, New York 10466, USA.

Journal of Clinical Gastroenterology
|December 19, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Opioid use patterns in US patients hospitalized with mild acute pancreatitis.

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]·2026
Same author

Adult Chronic Pancreatitis Working Group: Goals, Accomplishments and the Path Ahead. A Report From the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer.

Pancreas·2026
Same author

Natural History of Recurrent Acute Pancreatitis: Implications for Interventional Trial Design.

Alimentary pharmacology & therapeutics·2026
Same author

An Association of Mast-Cell Activation in the Pathogenesis of Recurrent Idiopathic Acute Pancreatitis.

Pancreas·2026
Same author

Heart Rate Variability as a Tell-tale Marker of Pain-related Autonomic Dysfunction in Chronic Pancreatitis.

Pancreas·2026
Same author

Treatment of Idiopathic Acute Pancreatitis With Pancreas Divisum-Reply.

JAMA·2026

Hypertriglyceridemia (HTG), a rare cause of pancreatitis, requires managing high triglyceride levels. Lowering TG below 1,000 mg/dL effectively prevents recurrent pancreatitis episodes.

Area of Science:

  • Gastroenterology
  • Endocrinology
  • Metabolic Diseases

Background:

  • Hypertriglyceridemia (HTG) is an uncommon but significant cause of acute pancreatitis (AP).
  • Patients often have pre-existing lipid abnormalities exacerbated by secondary factors like diabetes or alcohol use.
  • Serum triglyceride levels exceeding 1,000-2,000 mg/dL are key risk factors.

Purpose of the Study:

  • To review the etiology, clinical presentation, and management of hypertriglyceridemia-induced pancreatitis (HLP).
  • To highlight the importance of identifying secondary causes and managing lipid levels.

Main Methods:

  • Review of existing literature on hypertriglyceridemia and pancreatitis.
  • Analysis of clinical profiles and risk factors associated with hyperlipidemic pancreatitis.

Related Experiment Videos

  • Evaluation of current treatment strategies and their efficacy.

    • Main Results:

    • HLP typically presents as acute or recurrent pancreatitis, rarely chronic.
    • Pancreatic enzyme levels can be normal or minimally elevated despite severe pancreatitis.
    • The clinical course of HLP is similar to pancreatitis from other causes.

    Conclusions:

    • Effective management involves dietary fat restriction and lipid-lowering medications, primarily fibric acid derivatives.
    • Reducing triglyceride levels below 1,000 mg/dL is crucial for preventing recurrent pancreatitis.
    • Identifying and addressing secondary causes of HTG is essential for comprehensive patient care.